Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, CVD), By End User (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within Immediate
Digital Therapeutics Market Growth & Trends
The global digital therapeutics market size is anticipated to reach USD 32.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a lucrative CAGR of 26.1% from 2022 to 2030. Key factors driving the market growth include high demand due to the COVID-19 pandemic, various supportive regulatory initiatives & early signs of reimbursements, increasing smartphone penetration in developed & developing countries, and the growing prevalence of chronic disorders. Moreover, the cost-effectiveness of digital health technology for providers & patients and increasing demand for integrated healthcare systems & patient-centric care are estimated to boost the market growth.
The COVID-19 pandemic catalyzed the adoption of digital therapeutics solutions. Teladoc reported that telehealth usage grew by about 38 times since pre-pandemic. The adoption of these solutions was further supported by supportive initiatives by key regulatory bodies, such as the FDA. For instance, the U.S. FDA released guidelines in April 2020 to expand the availability of digital health therapeutic devices for psychiatric patients. As per Kepios, globally, the number of internet users is growing at an annual rate of 7.6%, i.e., an average addition of 900,000 new users every day. While developed and certain developing economies have high smartphone and internet penetration, countries in regions, such as Africa and South Asia, are lagging due to their less advanced economies.
With a modest user base, Africa’s smartphone market is expected to grow due to the advent of affordable handsets in the country. These handsets are priced under USD 100 per unit and are gaining popularity. The need for cost-effective healthcare is increasing due to the growing healthcare expenditure. The rising incidence of chronic diseases has led to an increase in healthcare costs. This has affected economic growth in developing and developed economies. To promote cheaper and alternative means of healthcare delivery, digital health technologies are being encouraged to help avoid added costs. The ease of usage of mHealth apps and their consistent performance can help improve health outcomes of individuals and communities, which is anticipated to have a positive impact on market growth.
Digital Therapeutics Market Report Highlights
Digital Therapeutics Market Growth & Trends
The global digital therapeutics market size is anticipated to reach USD 32.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a lucrative CAGR of 26.1% from 2022 to 2030. Key factors driving the market growth include high demand due to the COVID-19 pandemic, various supportive regulatory initiatives & early signs of reimbursements, increasing smartphone penetration in developed & developing countries, and the growing prevalence of chronic disorders. Moreover, the cost-effectiveness of digital health technology for providers & patients and increasing demand for integrated healthcare systems & patient-centric care are estimated to boost the market growth.
The COVID-19 pandemic catalyzed the adoption of digital therapeutics solutions. Teladoc reported that telehealth usage grew by about 38 times since pre-pandemic. The adoption of these solutions was further supported by supportive initiatives by key regulatory bodies, such as the FDA. For instance, the U.S. FDA released guidelines in April 2020 to expand the availability of digital health therapeutic devices for psychiatric patients. As per Kepios, globally, the number of internet users is growing at an annual rate of 7.6%, i.e., an average addition of 900,000 new users every day. While developed and certain developing economies have high smartphone and internet penetration, countries in regions, such as Africa and South Asia, are lagging due to their less advanced economies.
With a modest user base, Africa’s smartphone market is expected to grow due to the advent of affordable handsets in the country. These handsets are priced under USD 100 per unit and are gaining popularity. The need for cost-effective healthcare is increasing due to the growing healthcare expenditure. The rising incidence of chronic diseases has led to an increase in healthcare costs. This has affected economic growth in developing and developed economies. To promote cheaper and alternative means of healthcare delivery, digital health technologies are being encouraged to help avoid added costs. The ease of usage of mHealth apps and their consistent performance can help improve health outcomes of individuals and communities, which is anticipated to have a positive impact on market growth.
Digital Therapeutics Market Report Highlights
- The diabetes application segment dominated the market in 2021 due to the high prevalence of diabetes
- The patients' end-user segment held the maximum revenue share in 2021 owing to the high adoption of digital therapeutic solutions by patients
- In 2021, North America was the dominant regional market owing to the increased use of digital health products and favorable reimbursement scenarios that focus on improving quality of life through improved tracking & diagnostics
- Asia Pacific region is expected to register the fastest CAGR over the forecast period owing to the growing demand for personal care devices and related services
CHAPTER 1 RESEARCH METHODOLOGY & SCOPE
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Demand Sizing: Disease Prevalence Based Model
1.6.3 Region Based Segment Share Calculation
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 Report Objectives
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.1.1 Digital Therapeutics Market Outlook, 2017 - 2030 (USD Million)
2.2 Digital Therapeutics Market Summary, 2021
CHAPTER 3 DIGITAL THERAPEUTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Digital Therapeutics Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 COVID-19 pandemic
3.3.1.2 Supportive regulatory initiatives & early signs of reimbursement
3.3.1.3 Increasing prevalence of chronic diseases
3.3.1.4 increasing smartphone penetration in developed and developing countries
3.3.1.5 cost-effectiveness of digital health technology for providers and patients
3.3.1.6 increasing demand for integrated healthcare systems and patient-centric care
3.3.2 Market restraint analysis
3.3.2.1 low smartphone penetration in underdeveloped countries
3.3.2.2 COncerns over data protection
3.4 Digital Therapeutics Market Analysis Tools: Porter’s Five Forces Analysis
3.4.1 Supplier Power: Low
3.4.2 Buyer Power: high
3.4.3 Threat Of Substitutes: Low
3.4.4 Threat Of New Entrants: High
3.4.5 Competitive Rivalry: High
3.5 Pestel Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social & Technological Landscape
3.6 Opportunity Analysis
CHAPTER 4 DIGITAL THERAPEUTICS MARKET: COMPETITIVE ANALYSIS
4.1 Market Participation Categorization
4.1.1 Market Leaders & Innovators
4.1.1.1 company market position analysis
4.2 Major Deals & Strategic Alliances Analysis
4.2.1 List Of Private Companies
CHAPTER 5 DIGITAL THERAPEUTICS MARKET: COVID-19 IMPACT
5.1 Disease Prevalence Analysis
5.2 Current And Future Impact Analysis
5.2.1 Current Impact Analysis
5.2.2 Future Impact Analysis
5.3 Impact On Market Players
CHAPTER 6 DIGITAL THERAPEUTICS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1 Application Market Share Analysis, 2021 & 2030
6.2 Application Dashboard
6.3 Diabetes
6.3.1 diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
6.4 OBESITY
6.4.1 obesity market estimates and forecasts, 2017 - 2030 (USD Million)
6.5 CVD
6.5.1 CVD market estimates and forecasts, 2017 - 2030 (USD Million)
6.6 Respiratory Diseases
6.6.1 Respiratory diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.7 Smoking Cessation
6.7.1 Smoking cessation market estimates and forecasts, 2017 - 2030 (USD Million)
6.8 CNS DISEASES
6.8.1 CNS Diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.9 OTHERS
6.9.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
CHAPTER 7 DIGITAL THERAPEUTICS MARKET: END-USE ESTIMATES & TREND ANALYSIS
7.1 End-Use Market Share Analysis, 2021 & 2030
7.2 End-Use Dashboard
7.3 Patients
7.3.1 Patients Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4 Providers
7.4.1 Providers market estimates and forecasts, 2017 - 2030 (USD Million)
7.5 Payers
7.5.1 payers market estimates and forecasts, 2017 - 2030 (USD Million)
7.6 Employers
7.6.1 employers market estimates and forecasts, 2017 - 2030 (USD Million)
7.7 Other End Users
7.7.1 Other End Users market estimates and forecasts, 2017 - 2030 (USD Million)
CHAPTER 8 DIGITAL THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY APPLICATION, END-USE
8.1 Regional Market Snapshot
8.2 North America
8.2.1 North America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Digital Therapeutics Market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Digital Therapeutics market estimates and forecasts, 2017 - 2030(USD Million)
8.3.3 Germany
8.3.3.1 Germany Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.2 Mexico
8.5.2.1 Mexico Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.3 Brazil
8.5.3.1 Brazil Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6 Middle East And Africa (MEA)
8.6.1 Middle East and Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
CHAPTER 9 COMPANY PROFILES
9.1 OMADA HEALTH, INC.
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 WELLDOC, INC.
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 2Morrow, Inc
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 STRATEGIC INITIATIVES
9.4 LIVONGO HEALTH, INC. (TELADOC HEALTH, INC.)
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 PROPELLER HEALTH
9.5.1 Company Overview
9.5.2 Financial PERFORMANCE
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Fitbit, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 STRATEGIC INITIATIVES
9.7 CANARY HEALTH
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 MANGO HEALTH
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 STRATEGIC INITIATIVES
9.9 NOOM, INC.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 STRATEGIC INITIATIVES
9.10 PEAR THERAPEUTICS
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 STRATEGIC INITIATIVES
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Demand Sizing: Disease Prevalence Based Model
1.6.3 Region Based Segment Share Calculation
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 Report Objectives
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.1.1 Digital Therapeutics Market Outlook, 2017 - 2030 (USD Million)
2.2 Digital Therapeutics Market Summary, 2021
CHAPTER 3 DIGITAL THERAPEUTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Digital Therapeutics Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 COVID-19 pandemic
3.3.1.2 Supportive regulatory initiatives & early signs of reimbursement
3.3.1.3 Increasing prevalence of chronic diseases
3.3.1.4 increasing smartphone penetration in developed and developing countries
3.3.1.5 cost-effectiveness of digital health technology for providers and patients
3.3.1.6 increasing demand for integrated healthcare systems and patient-centric care
3.3.2 Market restraint analysis
3.3.2.1 low smartphone penetration in underdeveloped countries
3.3.2.2 COncerns over data protection
3.4 Digital Therapeutics Market Analysis Tools: Porter’s Five Forces Analysis
3.4.1 Supplier Power: Low
3.4.2 Buyer Power: high
3.4.3 Threat Of Substitutes: Low
3.4.4 Threat Of New Entrants: High
3.4.5 Competitive Rivalry: High
3.5 Pestel Analysis
3.5.1 Political & Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social & Technological Landscape
3.6 Opportunity Analysis
CHAPTER 4 DIGITAL THERAPEUTICS MARKET: COMPETITIVE ANALYSIS
4.1 Market Participation Categorization
4.1.1 Market Leaders & Innovators
4.1.1.1 company market position analysis
4.2 Major Deals & Strategic Alliances Analysis
4.2.1 List Of Private Companies
CHAPTER 5 DIGITAL THERAPEUTICS MARKET: COVID-19 IMPACT
5.1 Disease Prevalence Analysis
5.2 Current And Future Impact Analysis
5.2.1 Current Impact Analysis
5.2.2 Future Impact Analysis
5.3 Impact On Market Players
CHAPTER 6 DIGITAL THERAPEUTICS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1 Application Market Share Analysis, 2021 & 2030
6.2 Application Dashboard
6.3 Diabetes
6.3.1 diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
6.4 OBESITY
6.4.1 obesity market estimates and forecasts, 2017 - 2030 (USD Million)
6.5 CVD
6.5.1 CVD market estimates and forecasts, 2017 - 2030 (USD Million)
6.6 Respiratory Diseases
6.6.1 Respiratory diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.7 Smoking Cessation
6.7.1 Smoking cessation market estimates and forecasts, 2017 - 2030 (USD Million)
6.8 CNS DISEASES
6.8.1 CNS Diseases market estimates and forecasts, 2017 - 2030 (USD Million)
6.9 OTHERS
6.9.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
CHAPTER 7 DIGITAL THERAPEUTICS MARKET: END-USE ESTIMATES & TREND ANALYSIS
7.1 End-Use Market Share Analysis, 2021 & 2030
7.2 End-Use Dashboard
7.3 Patients
7.3.1 Patients Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4 Providers
7.4.1 Providers market estimates and forecasts, 2017 - 2030 (USD Million)
7.5 Payers
7.5.1 payers market estimates and forecasts, 2017 - 2030 (USD Million)
7.6 Employers
7.6.1 employers market estimates and forecasts, 2017 - 2030 (USD Million)
7.7 Other End Users
7.7.1 Other End Users market estimates and forecasts, 2017 - 2030 (USD Million)
CHAPTER 8 DIGITAL THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY APPLICATION, END-USE
8.1 Regional Market Snapshot
8.2 North America
8.2.1 North America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Digital Therapeutics Market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Digital Therapeutics market estimates and forecasts, 2017 - 2030(USD Million)
8.3.3 Germany
8.3.3.1 Germany Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.2 Mexico
8.5.2.1 Mexico Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.3 Brazil
8.5.3.1 Brazil Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6 Middle East And Africa (MEA)
8.6.1 Middle East and Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million)
CHAPTER 9 COMPANY PROFILES
9.1 OMADA HEALTH, INC.
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 WELLDOC, INC.
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 2Morrow, Inc
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 STRATEGIC INITIATIVES
9.4 LIVONGO HEALTH, INC. (TELADOC HEALTH, INC.)
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 PROPELLER HEALTH
9.5.1 Company Overview
9.5.2 Financial PERFORMANCE
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Fitbit, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 STRATEGIC INITIATIVES
9.7 CANARY HEALTH
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 MANGO HEALTH
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 STRATEGIC INITIATIVES
9.9 NOOM, INC.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 STRATEGIC INITIATIVES
9.10 PEAR THERAPEUTICS
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 STRATEGIC INITIATIVES
LIST OF TABLES
Table 1 Primary interview details: North America
Table 2 Primary interview details: Europe
Table 3 Primary interview details: Asia Pacific
Table 4 Primary interview details: Latin America
Table 5 Primary interview details: Middle East and Africa
Table 6 List of secondary sources
Table 7 Digital Therapeutics Apps approved for prescription & reimbursement by BfArM, Germany
Table 8 Number of smartphone users globally (Million)
Table 9 List of private companies
Table 10 North America Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 11 North America digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 12 U.S. Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 13 U.S. digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 14 Canada Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 15 Canada digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 16 Europe Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 17 Europe digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 18 U.K. Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 19 U.K. digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 20 Germany Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 21 Germany digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 22 France Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 23 France digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 24 Italy Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 25 Italy digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 26 Spain Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 27 Spain digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 28 Asia Pacific Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 29 Asia Pacific digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 30 Japan Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 31 Japan digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 32 China Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 33 China digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 34 India Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 35 India digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 36 Latin America Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 37 Latin America digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 38 Brazil Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 39 Brazil digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 40 Mexico Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 41 Mexico digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 42 Argentina Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 43 Argentina digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 44 MEA Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 45 MEA digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 46 South Africa Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 47 South Africa digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 48 Saudi Arabia Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 49 Saudi Arabia digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 1 Primary interview details: North America
Table 2 Primary interview details: Europe
Table 3 Primary interview details: Asia Pacific
Table 4 Primary interview details: Latin America
Table 5 Primary interview details: Middle East and Africa
Table 6 List of secondary sources
Table 7 Digital Therapeutics Apps approved for prescription & reimbursement by BfArM, Germany
Table 8 Number of smartphone users globally (Million)
Table 9 List of private companies
Table 10 North America Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 11 North America digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 12 U.S. Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 13 U.S. digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 14 Canada Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 15 Canada digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 16 Europe Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 17 Europe digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 18 U.K. Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 19 U.K. digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 20 Germany Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 21 Germany digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 22 France Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 23 France digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 24 Italy Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 25 Italy digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 26 Spain Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 27 Spain digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 28 Asia Pacific Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 29 Asia Pacific digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 30 Japan Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 31 Japan digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 32 China Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 33 China digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 34 India Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 35 India digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 36 Latin America Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 37 Latin America digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 38 Brazil Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 39 Brazil digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 40 Mexico Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 41 Mexico digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 42 Argentina Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 43 Argentina digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 44 MEA Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 45 MEA digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 46 South Africa Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 47 South Africa digital therapeutics market, by end user, 2017 - 2030 (USD Million)
Table 48 Saudi Arabia Digital therapeutics market, by application, 2017 - 2030 (USD Million)
Table 49 Saudi Arabia digital therapeutics market, by end user, 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Digital therapeutics market revenue (USD Million)
Fig. 11 Digital Therapeutics Market Snapshot
Fig. 12 Parent market outlook
Fig. 13 Ancillary market outlook
Fig. 14 Penetration & growth prospect mapping, 2021
Fig. 15 Digital Therapeutics market dynamics
Fig. 16 Digital Therapeutics market driver impact
Fig. 17 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
Fig. 18 Top countries by smartphone users, 2020
Fig. 19 Digital Therapeutics market restraint impact
Fig. 20 Market Participation Categorization
Fig. 21 Market leaders and innovators
Fig. 22 Company market position analysis
Fig. 23 Major deals & strategic alliances analysis
Fig. 24 COVID-19 confirmed cases around the world
Fig. 25 Digital Therapeutics market: Application movement analysis
Fig. 26 Digital Therapeutics Market: Application Dashboard
Fig. 27 Global diabetes market, 2017 - 2030 (USD Million)
Fig. 28 Global obesity market, 2017- 2030 (USD Million)
Fig. 29 Global CVD market, 2017- 2030 (USD Million)
Fig. 30 Global respiratory diseases market, 2017 - 2030 (USD Million)
Fig. 31 Global smoking cessation market, 2017 - 2030 (USD Million)
Fig. 32 Global CNS diseases market, 2017- 2030 (USD Million)
Fig. 33 Global others market, 2017- 2030 (USD Million)
Fig. 34 Digital Therapeutics market: End-use movement analysis
Fig. 35 Digital Therapeutics Market: End-use Dashboard
Fig. 36 Global patients market, 2017- 2030 (USD Million)
Fig. 37 Global providers market, 2017 - 2030 (USD Million)
Fig. 38 Global payers market, 2017 - 2030 (USD Million)
Fig. 39 Global employers market, 2017 - 2030 (USD Million)
Fig. 40 Global other end users market, 2017 - 2030 (USD Million)
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 43 U.S. Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 44 Canada Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 45 Europe Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 46 U.K. Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 47 Germany Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 48 France Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 49 Italy Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 50 Spain Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 51 Asia Pacific Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 52 Japan Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 53 China Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 54 India Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 55 Latin America Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 56 Mexico Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 57 Brazil Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 58 Argentina Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 59 Middle East and Africa Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 60 South Africa Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 61 Saudi Arabia Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Digital therapeutics market revenue (USD Million)
Fig. 11 Digital Therapeutics Market Snapshot
Fig. 12 Parent market outlook
Fig. 13 Ancillary market outlook
Fig. 14 Penetration & growth prospect mapping, 2021
Fig. 15 Digital Therapeutics market dynamics
Fig. 16 Digital Therapeutics market driver impact
Fig. 17 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
Fig. 18 Top countries by smartphone users, 2020
Fig. 19 Digital Therapeutics market restraint impact
Fig. 20 Market Participation Categorization
Fig. 21 Market leaders and innovators
Fig. 22 Company market position analysis
Fig. 23 Major deals & strategic alliances analysis
Fig. 24 COVID-19 confirmed cases around the world
Fig. 25 Digital Therapeutics market: Application movement analysis
Fig. 26 Digital Therapeutics Market: Application Dashboard
Fig. 27 Global diabetes market, 2017 - 2030 (USD Million)
Fig. 28 Global obesity market, 2017- 2030 (USD Million)
Fig. 29 Global CVD market, 2017- 2030 (USD Million)
Fig. 30 Global respiratory diseases market, 2017 - 2030 (USD Million)
Fig. 31 Global smoking cessation market, 2017 - 2030 (USD Million)
Fig. 32 Global CNS diseases market, 2017- 2030 (USD Million)
Fig. 33 Global others market, 2017- 2030 (USD Million)
Fig. 34 Digital Therapeutics market: End-use movement analysis
Fig. 35 Digital Therapeutics Market: End-use Dashboard
Fig. 36 Global patients market, 2017- 2030 (USD Million)
Fig. 37 Global providers market, 2017 - 2030 (USD Million)
Fig. 38 Global payers market, 2017 - 2030 (USD Million)
Fig. 39 Global employers market, 2017 - 2030 (USD Million)
Fig. 40 Global other end users market, 2017 - 2030 (USD Million)
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 43 U.S. Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 44 Canada Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 45 Europe Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 46 U.K. Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 47 Germany Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 48 France Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 49 Italy Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 50 Spain Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 51 Asia Pacific Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 52 Japan Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 53 China Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 54 India Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 55 Latin America Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 56 Mexico Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 57 Brazil Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 58 Argentina Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 59 Middle East and Africa Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 60 South Africa Digital Therapeutics market, 2017 - 2030 (USD Million)
Fig. 61 Saudi Arabia Digital Therapeutics market, 2017 - 2030 (USD Million)
